Pharmacy Question for the Week of June 12, 2017

Pharmacy Compliance Question of the Week

Question:

Do you know whether CMS has announced any new pass-through codes for the next quarter?

Answer:

Yes, effective July 1, 2017, the two codes below will assume pass-through status:

C9489 Injection, nusinersen, 0.1 mg
C9490 Injection, bezlotoxumab, 10 mg

Disclaimer: Every reasonable effort was made to ensure the accuracy of this information at the time it was published. However, due to the nature of industry changes over time we cannot guarantee its validity after the year it was published.